Matthews Judith M. 4/A
4/A · Iterum Therapeutics plc · Filed Mar 15, 2022
Insider Transaction Report
Form 4/AAmended
Matthews Judith M.
Chief Financial Officer
Transactions
- Sale
Ordinary Shares
2022-03-14$0.31/sh−63,340$19,635→ 65,292 total
Footnotes (2)
- [F1]Represents the ordinary shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of restricted share units. This amendment is being filed to address an error in reporting the number of ordinary shares sold pursuant to such election and the sale price per share. This sale does not represent a discretionary trade by the reporting person.
- [F2]Restricted share units converted into ordinary shares on a one-for-one basis upon vesting of the restricted share units. This amendment is being filed to address an error in reporting the number of ordinary shares sold pursuant to such election and the sale price per share. This sale does not represent a discretionary trade by the reporting person.